Senior Director, In Vivo Therapeutics
3 weeks ago
We believe our people are at the core of everything we do, and we’re committed to cultivating a culture where every individual feels valued and included. To do this, we strive to integrate belonging, inclusivity, diversity, and equity into every aspect of our organization.
Together, we are leading the way towards a healthier and more equitable future.
Position Summary
Editas Medicine is seeking a highly motivated and dynamic leader with proven translational research experience to direct the discovery and advancement of in vivo genome editing medicines for the treatment of serious genetic diseases. This individual will serve as a scientific advisor and lead teams of scientists in the design of project strategies and plans based on understanding of intended indications, patient populations, and endpoints, gleaned through cross-functional interactions with clinical, nonclinical, and translational collaborators. The successful candidate must have a proven track record in the discovery and development of drugs targeting diseases of non-CNS/peripheral tissues at least through IND, with more than one modality including biologics, small molecules, nucleic acid-based, or gene therapy products; and possess a solid understanding of FDA/EMA guidelines. This individual will be collaborative, with proven ability to manage and develop individuals and teams to meet goals, with sensitivity to timelines while maintaining high quality performance.
Key Responsibilities:
As the Senior Director, In Vivo Gene Editing Therapeutics, you will be responsible for:
Leverage drug development experience and subject matter expertise in peripheral indication space to guide target identification evaluations, prioritizations, and the development of project strategies with a robust chain of translatability from research to clinic.
Serve as a scientific advisor to project teams for operational planning, including timelines and deliverables, and engage and align stakeholders across functions to enable advancement of Editas’ pipeline of in vivo medicines.
Lead efforts from early discovery to development candidate nomination, and support thereafter to fulfill needs of development program, e.g., regulatory filings, input to biomarker plan.
Manage and mentor a diverse team of scientists to build their competencies in drug development, and strategic development of project plans.
Develop cross-functional lines of communication to promote workstreams, and mentor project leads to develop lines of communication for coordinating project work with functional stakeholders and to manage CROs and collaborators as needed.
Manage CROs, academic collaborators, and KOLs.
Establish SOPs, write prospective protocols, author study reports and regulatory documents, assist patent filing, and contribute to business development activities.
Serve as a technical and scientific resource for junior staff.
Manage diverse team interactions. Be a dedicated people manager to positively influence our culture.
Requirements
Required Qualifications:
The ideal candidate will possess:
Ph.D. with minimum of 15 years of working experience, including proven track record in the discovery and development of drugs for diseases of peripheral tissues/organs in the pharmaceutical and/or biotechnology industry, substantiated by publications, patent filings, and/or other, from tenure in drug discovery and development as characterized.
Subject matter expertise in disease(s) of peripheral indication space as demonstrated by publications and/or track record is highly desirable.
Working experience with lipid nanoparticles for targeted delivery in vivo is highly desirable.
Familiarity with FDA and EMA guidance for cell and gene therapy and experience with IND-filing.
A minimum of five years managerial experience that demonstrates effective leadership in a cross-functional setting.
Preferred Qualifications:
Additionally, candidates with the following attributes are preferred:
Ability to think strategically to develop project plans to enable rapid, data-driven decision-making.
Ability to critically, synthesize and extract simple principles from complex datasets.
Ability to communicate effectively across a broad spectrum of audience both internal and external to Editas, in both oral and written form.
Excellent collaboration skills with proven ability to thrive in matrixed environment.
Attention to detail and ability to conduct high-quality research and execute research plans in a timely and organized manner.
Capable of innovating approaches to drive programs forward.
Comfortable working in fast-paced environment and able to adjust quickly to changing priorities.
Benefits
Benefits Summary:
Editas provides a comprehensive array of benefits to all employees, including a Blue Cross Blue Shield PPO Medical Plan, a company-funded Health Savings Account, Dental and Vision Insurance, Life and Disability Insurance, Dependent Care Account, Tuition Reimbursement, 401(k) plan with company match, Employee Stock Purchase Plan, Employee Assistance Plan, Wellness Programs, and a flexible Paid Time Off policy.
If you are a results-focused and collaborative professional with a passion for advancing transformative therapies, we invite you to apply. Join us at the forefront of genetic innovation and be a key contributor to Editas Medicine's mission of redefining healthcare through cutting-edge genetic technologies.
Fostering Belonging. Fueling Innovation. Transforming Lives.
-
Senior Director, In Vivo Therapeutics
2 weeks ago
Cambridge, United States Editas Medicine, Inc. Full timeAt Editas, we're driven by a collective purpose, to bring transformative and life changing therapies to people living with serious diseases with the greatest unmet needs. This fuels our drive to excel in scientific innovation, allowing us to harness the power and potential of CRISPR/Cas9 and CRISPR/Cpf1 (Cas12a) gene editing. We believe our people are at...
-
Senior Director, In Vivo Therapeutics
3 weeks ago
Cambridge, United States Editas Medicine Full timeJob DescriptionJob DescriptionAt Editas, we’re driven by a collective purpose, to bring transformative and life changing therapies to people living with serious diseases with the greatest unmet needs. This fuels our drive to excel in scientific innovation, allowing us to harness the power and potential of CRISPR/Cas9 and CRISPR/Cpf1 (Cas12a) gene editing....
-
Senior Director, In Vivo Therapeutics
2 weeks ago
Cambridge, United States Editas Medicine Full timeJob DescriptionJob DescriptionAt Editas, we’re driven by a collective purpose, to bring transformative and life changing therapies to people living with serious diseases with the greatest unmet needs. This fuels our drive to excel in scientific innovation, allowing us to harness the power and potential of CRISPR/Cas9 and CRISPR/Cpf1 (Cas12a) gene editing....
-
Sr. Research Associate
2 weeks ago
Cambridge, United States Fulcrum Therapeutics, Inc. Full timeCompany Overview Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum's two lead programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and...
-
Sr. Scientist II, In Vivo Therapeutics Discovery
3 weeks ago
Cambridge, Massachusetts, United States Editas Medicine Full timeAt Editas, we’re driven by a collective purpose, to bring transformative and life changing therapies to people living with serious diseases with the greatest unmet needs. This fuels our drive to excel in scientific innovation, allowing us to harness the power and potential of CRISPR/Cas9 and CRISPR/Cpf1 (Cas12a) gene editing. We believe our people are at...
-
Scientist, In Vivo Biology
4 weeks ago
Cambridge, United States GC Therapeutics Full timeCompany Overview GC Therapeutics is the first genome-wide cell landscape exploration company using an integrated synthetic biology and AI-driven platform for cell programming. Its patent-pending and proprietary pluripotent stem cell differentiation technology platform TFome™ was developed in Professor George Church’s lab, a pioneer in synthetic biology,...
-
Scientist, In Vivo Biology
3 weeks ago
Cambridge, United States GC Therapeutics Full timeCompany Overview GC Therapeutics is the first genome-wide cell landscape exploration company using an integrated synthetic biology and AI-driven platform for cell programming. Its patent-pending and proprietary pluripotent stem cell differentiation technology platform TFome™ was developed in Professor George Church’s lab, a pioneer in synthetic biology,...
-
Cambridge, Massachusetts, United States Biogen Full timeJob Description About This Role Translational In Vivo Sciences (TIVS) at Biogen is seeking a Senior Associate Scientist to join a cross-functional research effort to enhance the delivery of Biogen’s therapeutics to the central nervous system (CNS) and muscle. These efforts will be applied across multiple therapeutic areas in the neurological and...
-
Scientist, Translational In Vivo Sciences
2 weeks ago
Cambridge, Massachusetts, United States Biogen Full timeJob Description About This Role Translational In Vivo Sciences is seeking a scientist to join a cross-functional research effort to enhance the delivery of Biogen’s therapeutics to the central nervous system (CNS) and muscle. These efforts will be applied across multiple therapeutic areas in the neurological and neuromuscular space, supporting portfolio...
-
Cambridge, United States Adaptimmune Therapeutics plc Full timeAdaptimmune is a fully integrated cell therapy company, designed and built from the ground up with four U.K.- and U.S.-based biotechnology hub locations. Our comprehensive capabilities and teams include preclinical research, clinical development, translational sciences, autologous and allogeneic manufacturing, and in-house commercial and corporate...
-
Director, Senior Director Genome Engineering
3 weeks ago
Cambridge, United States Voyager Therapeutics Full timeAbout Voyager Therapeutics Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple...
-
Contract Research Associate, in Vivo
3 days ago
Cambridge, United States Orbital Therapeutics Full time**Company Summary**: Orbital Therapeutics aims to enhance global health by unleashing the full potential of RNA-based medicines (excluding small interfering RNA) to treat human disease in ways that were not previously possible. The company is building a first-in-kind platform at the intersection of RNA technology, delivery methods, data science and...
-
Director, Senior Director Genome Engineering
3 days ago
Cambridge, United States Voyager Therapeutics, Inc. Full timeAbout Voyager Therapeutics Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of - and ultimately cure - neurological diseases. Our pipeline includes programs for Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Parkinson's disease, and multiple other diseases...
-
Sr. Scientist II, In Vivo Therapeutics Discovery
3 weeks ago
Cambridge, United States Editas Medicine Full timeJob DescriptionJob DescriptionAt Editas, we’re driven by a collective purpose, to bring transformative and life changing therapies to people living with serious diseases with the greatest unmet needs. This fuels our drive to excel in scientific innovation, allowing us to harness the power and potential of CRISPR/Cas9 and CRISPR/Cpf1 (Cas12a) gene...
-
Sr. Research Associate
2 weeks ago
Cambridge, United States Third Rock Ventures Full timeFulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases in areas of high unmet medical need. Fulcrum's two lead programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and pociredir, a small...
-
Senior Manager, Statistical Programming
2 weeks ago
Cambridge, Massachusetts, United States Bicycle Therapeutics Full timeJob Description The Senior Manager Statistical Programming will act as statistical programming lead for various clinical studies. You will collaborate with Biostatisticians and Statistical Programmers and ensure high quality and timely statistical programming deliverables. You also will perform oversight on the counterpart from vendors. You will report to...
-
Director, Biology
15 hours ago
Cambridge, United States Delphia Therapeutics Full timeAbout Us:Delphia is igniting a new field of therapeutics in hopes to transform the care of cancer patients. Together, we are working to advance first-in-class targeted cancer medicines leveraging Activation Lethality, a new field of cancer biology centered on cancer’s surprising vulnerability to oncogene overactivation. While a bold idea, activation...
-
Associate In Vivo Scientist
4 weeks ago
Cambridge, Massachusetts, United States Eli Lilly and Company Full timeAt Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities...
-
Director, Anti-Fungal Drug Discovery
2 weeks ago
Cambridge, United States LifeMine Therapeutics Full timeJob Summary We are seeking a highly motivated drug discovery leader to join our growing fungal biology team located in Cambridge, MA. The ideal candidate will have made substantial contributions to the identification of new targets and drug discovery/translational research efforts in the anti-fungal therapeutic area including involvement in strategic...
-
Cambridge, United States Adaptimmune Full timeAdaptimmune is a fully integrated cell therapy company, designed and built from the ground up with four U.K.- and U.S.-based biotechnology hub locations. Our comprehensive capabilities and teams include preclinical research, clinical development, translational sciences, autologous and allogeneic manufacturing, and in-house commercial and corporate...
